Physician

Internal Medicine

Udaya Kabadi works in the field of Internal Medicine. He studied medicine at Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20/62 in Research/PrimaryCare. He over the years received 1 awards: "Fellow (FACE)". Udaya Kabadi is a published physician as well. He has 100 publications published. The latest was: Decreased plasma insulin but normal glucagon in rats fed low protein diets. Udaya Kabadi accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Elevated fructosamine levels in acquired immunoDeficiency syndrome.
• Serum thyrotropin in Graves' disease: a more reliable index of circulating Thyroid-stimulating immunoglobulin level than Thyroid function?
• Role of thyrotropin in metabolism of Thyroid hormones in nonThyroidal tissues.
• Cost-effective management of hyperglycemia in patients with type 2 Diabetes using oral agents.
• Effects of glimepiride on insulin secretion and sensitivity in patients with recently diagnosed type 2 Diabetes mellitus.
• Efficacy of sulfonylureas with insulin in type 2 Diabetes mellitus.
• Insulin glargine in continuous enteric tube feeding.
• United Kingdom prospective Diabetes study: a different perspective.
• A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.
• Therapeutic 131I dose in hyperThyroidism: role of pretreatment with thionamide.
• Optimal LT4 dosage in primary hypoThyroidism.
• Impaired TSH secretion during sustained hyperglucagonemia in anesthetized dogs.
• Giant ruptured thyroglossal cyst.
• A variant of adrenomyeloneuropathy With hypothalamic-pituitary dysfunction and neurologic remission after glucocorticoid replacement therapy.
• Familial hypoThyroidism manifested by painful, swollen joints.
• Is beta-cell failure in type 2 Diabetes mellitus reversible?
• Intensive insulin therapy in critical care settings.
• Corticotropin-induced hyperaldosteronism; causing hypokalemic paralysis of thyrotoxicosis.
• Laboratory tests for evaluating Thyroid therapy.
• A clinical trial With glycodiazine--a new oral antidiabetic compound.
• A clinical trial With glycodiazine--a new oral antidiabetic compound--appraisal of a single daily dose regime.
• Management of Diabetes in pulmonary tuberculosis.
• Onset of type I diabetes mellitus, hypoThyroidism, and hypogonadism on withdrawal of glucocorticoid therapy and remission on its resumption in a patient with rheumatoi...
• Normal thyrotrophin response to intravenous thyrotrophin releasing hormone administration: the best index of optimal L-thyroxine therapy in primary hypoThyroidism.
• Glucagon administration induces lowering of serum T3 and rise in reverse T3 in euThyroid healthy subjects.
• Adjuvant therapy with tolazamide and insulin improves metabolic control in type I Diabetes mellitus.
• Elevated plasma ammonia level in hepatic cirrhosis: role of glucagon.
• Misleading thyroid function tests and several homeostatic Abnormalities induced by "disalcid" therapy.
• Serum T3 and reverse T3 concentrations: indices of metabolic control in Diabetes mellitus.
• Diabetic retinopathy, nephropathy, and neuropathy With normal glucose tolerance.
• Lowering of serum T3 and rise in reverse T3 induced by glucagon infusion in anaesthetized dogs.
• Acute psychosis in a patient receiving trimethoprim-sulfamethoxazole intravenously.
• Lowering of T3 and rise in reverse T3 induced by hyperglucagonemia: altered Thyroid hormone metabolism, not altered release of Thyroid hormones.
• Unilateral vocal cord palsy in a diabetic patient.
• Glycosylation of proteins. Lack of influence of aging.
• The association of hepatic glycogen depletion With hyperammonemia in cirrhosis.
• Decline of T3 and elevation in reverse T3 induced by hyperglucagonemia: changes in Thyroid hormone metabolism, not altered release of Thyroid hormones.
• Thyroid hormone indices in adult healthy subjects: no influence of aging.
• Variability of L-thyroxine replacement dose in elderly patients with primary hypoThyroidism.
• Improved metabolic control in insulin-dependent Diabetes mellitus with insulin and tolazamide.
• Nutritional therapy in Diabetes. Rationale and recommendations.
• Thyroid disorders and the elderly.
• Optimal daily levothyroxine dose in primary hypoThyroidism. Its relation to pretreatment Thyroid hormone indexes.
• Influence of low battery voltage on glucose testing meters.
• Pericardial effusion in primary hypoThyroidism.
• Self-monitoring of blood glucose in elderly diabetics: an unaffordable exercise in futility?
• Dose-kinetics of pancreatic alpha- and beta-cell responses to a protein meal in normal subjects.
• Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon.
• Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
• Classification of Diabetes according to National Diabetic Data Group.
• Glucagon-induced changes in plasma Thyroid hormone concentrations in healthy dogs resemble "euThyroid sick syndrome".
• Altered regulation of atrial natriuretic peptide in essential hypernatremia.
• Is hepatic glycogen content a regulator of glucagon secretion?
• Management of NIDDM.
• Elevated glycosylated hemoglobin concentrations in AIDS.
• Urine glucose testing: reliable backup for whole blood glucose monitoring.
• Metabolic control following transfer from mixed bovine-porcine insulin to human insulin in subjects With IDDM: influence of the presence of insulin antibodies.
• Decreased plasma insulin but normal glucagon in rats fed low protein diets.
• Trigeminal neuralgia in progressive systemic sclerosis.
• The hyperglycemic hyperosmolar syndrome.
• T3 euThyroidism in follicular Thyroid carcinoma.
• Hepatic regulation of pancreatic alpha-cell function.
• 'Subclinical hypoThyroidism'. Natural course of the syndrome during a prolonged follow-up study.
• Severe sensory motor polyneuropathy at the onset of Diabetes mellitus. Total remission with testosterone therapy following recognition of associated hypogonadism.
• Combination sulfonylurea and insulin therapy in non-insulin-dependent Diabetes mellitus.
• Falsely low serum thyroxine concentration measured With the Abbott TDx.
• Inhibition of glucagon secretion by crude liver extract in conscious dogs.
• The effect of recurrent practice at home on the acceptability of capillary blood glucose readings. Accuracy of self blood glucose testing.
• Serum thyrotropin in primary hypoThyroidism. A possible predictor of optimal daily levothyroxine dose in primary hypoThyroidism.
• Pancreatic ketoacidosis: ketonemia associated With acute pancreatitis.
• Acceptability of capillary blood glucose testing With Companion 2 after intensive individual patient training.
• Renal calculi in primary hyperaldosteronism.
• Low serum 3, 5, 3''-triiodothyronine (T3) and raised 3, 3'', 5''-triidothyronine (reverse T3 or RT3) in Diabetes mellitus: normalization on improvement in hyperglycemia.
• Diabetes mellitus: new classification.
• Diabetic amyotrophy With primary involvement of shoulder girdle.
• Impaired pancreatic alpha-cell response in hyperThyroidism.
• Glucose intolerance in hyperThyroidism: role of glucagon.
• Low triiodothyronine and raised reverse triiodothyronine levels in patients over fifty years of age who have type II Diabetes mellitus: influence of metabolic control,...
• Osteomalacia associated With prostatic cancer and osteoblastic metastases.
• Serum T3 and reverse T3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver Dysfunction.
• Laboratory evaluation of anatomic disorders of the Thyroid.
• Impaired pituitary thyrotroph function in uncontrolled type II Diabetes mellitus: normalization on recovery.
• Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular Dysfunction and normalization on recovery.
• The presence of glucagon in ascitic fluid in cirrhotic patients.
• Influence of age on optimal daily levothyroxine dosage in patients with primary hypoThyroidism grouped according to etiology.
• Normal thyroxine and elevated thyrotropin concentrations: evolving hypoThyroidism or persistent euThyroidism with reset thyrostat.
• Pancreatic alpha-cell function in idiopathic reactive hypoglycemia.
• The effect on metabolic control of second-generation sulfonylurea drugs in patients With NIDDM after secondary failure to first-generation agents.
• More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 Diabetes mellitus: role of enhance...
• Combinations sulfonylurea and insulin therapy in Diabetes mellitus.
• Efficacy of insulin and sulfonylurea combination therapy in type II Diabetes. A meta-analysis of the randomized placebo-controlled trials.
• Serum thyrotropin determinations: comparison of second- and third-generation assays.
• Successful outcome With methimazole and lithium combination therapy for propylthiouracil-induced hepatotoxicity.
• Inhibited hypothalamic-pituitary-Thyroid axis in type I pseudohypoparaThyroidism.
• Effects of carbamazepine on the hypothalamic-pituitary-Thyroid axis.
• Primary hyperaldosteronism.
• Thyroid hormone indices during illness in six hypoThyroid subjects rendered euThyroid with levothyroxine therapy.
• Thyrotropin dysregulation during a non-Thyroidal illness: transient hypothalamic hypoThyroidism?
• Serum thyrotropin in primary hypoThyroidism: a reliable and accurate predictor of optimal daily levothyroxine dose.

Schools

---

• University Of Mumbai Goa Medical College

• Jewish Meml Hospital

• Beth Israel Med Center

• Va Med Center

Conditions Treated

---

• Abnormal Thyroid
• Calcium Metabolism Disorders
• Craniopharyngioma
• Diabetes Type 1
• View All

Doctors Specialties

---

• Geriatric Medicine
• Internal Medicine

Accepted Insurances

---

• Choice Plus POS II
• Blue Card PPO
• Blue Cross Blue Shield of Illinois PPO
• CHAMPVA
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• Coventry Health Care
• Coventry Health Care of Iowa PPO
• GEHA
• Mail Handlers Benefit Plan (MHBP)
• Medicare MCR
• MultiPlan PPO
• Mutual of Omaha
• Principal Life
• United Healthcare
• Alliance Select

Awards

---

• Fellow (FACE)

Education

---

• Mount Sinai Beth Israel
• Icahn School of Medicine at Mount Sinai
• Seth G.S. Medical College

Drug Facts

---

NPI NUMBER		1770567786
NPPES Provider LastName		KABADI
NPPES Provider FirstName		UDAYA
NPPES Provider ZIPCode		522421082
NPPES Provider State		IA
Specialty Description		Endocrinology
Total Claim Count		437.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1770567786
Last Name Of The Provider	KABADI
First Name Of The Provider	UDAYA
View All

Similar Doctors

---

	Dr. David M. Huante, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrea K. Lang, MD
	Suzanne Ware, PA
	Dr. Shirley Pua, MD This Doctor is OpenDoctor Recommended.
	Dr. Monica A. Hoffman, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark R. Collison, MD This Doctor is OpenDoctor Recommended.
	Dr. Melisa A. Coaker, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog